Spotlight On Medical & Health: Trial and error
Clinical trials on humans is witnessing great technological advances, but they can be dangerous, as the Te Genero case proved in 2006. With compulsory insurance required, how can insurers manage the risks involved?
Insuring clinical trials, where prototype drugs or medical instruments are tested on humans, can be a minefield. One look at the infamous Te Genero trial back in 2006 shows exactly what can go wrong
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Personal
Axa triumphs over Google-spoofing advertiser
Keoghs and Axa have thwarted an attempt by a credit hire organisation to claim unrecovered hire charges from a consumer who was the victim of Google-spoofing fraud.
Big Interview: Ernesto Suarez, Gigasure
Ernesto Suarez, CEO of Gigasure, outlines his plan to turn the recently launched travel MGA into the neo-bank of insurance.
Gigasure CEO outlines pet and PCW plans
Ernesto Suarez, CEO of Gigasure, has told Insurance Post of the firm’s plans to be listed on multiple price comparison websites by the end of the year, and launch a pet product.
Ghost broker busting – how can they be blasted off social media?
Content Director's View: If there’s something weird selling motor cover and it don’t look good … why do so many young drivers fall for ghost brokers on social media and what can be done to bust them, asks Insurance Post's Jonathan Swift.
ABI’s Gurga urges regulators to slash red tape
Hannah Gurga, director general of the Association of British Insurers, has urged the government and regulators to grab Alexander the Great’s sword and slash through the Gordian knot of regulation.
Close Brothers to seek consent to pay premium finance commission
From next week, Close Brothers will seek consent from commercial customers for the payment of broker commissions for premium finance.
Axa’s Zweibrucker on why promoting road safety is essential
View from the Top: Alain Zweibrucker, CEO of Axa UK Retail, explains why the insurer called on the government to do more to promote road safety earlier this year.
Home insurers that reject half of claims named and shamed
Consumer watchdog Which? has named and shamed home insurers with a claims acceptance rate of less than 55%.